Chemotherapy News and Research

Latest Chemotherapy News and Research

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Ovarian cancer is the 9th most common cancer in women and although it only accounts for approximately 3 percent of cancers in women, it is responsible for the most deaths of any cancer involving the female reproductive tract.

20 Sep 2017

Increase in physical activity boosts breast cancer survivors’ mental processing speed

It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.

19 Sep 2017

Analytical Science in Precision Medicine

Pittcon is an analytical conference, so naturally my talk will be about analytical chemistry and how analytical chemistry will become increasingly important in delivering healthcare solutions, not only for rich people, but also, hopefully, for poor people across the world.

From Pittcon 19 Sep 2017

As care shifts from hospital to home, guarding against infection falls to families

Angela Cooper arrived home from work to discover her daughter’s temperature had spiked to 102 degrees — a sign that the teenager, who has cancer, had a potentially deadly bloodstream infection.

19 Sep 2017

Research shows how bacteria inactivate common drug used to treat cancers

To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published today in Science, researchers describe findings that certain bacteria can be found inside human pancreatic tumors.

18 Sep 2017

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Hospital pharmacist Mandy Langston remembers when Lulabelle Berry arrived at Stone County Medical Center's emergency department last year.

18 Sep 2017

Study highlights complexity of childhood cancer survivors’ medical needs

Survivors of childhood cancer may experience, on average, nearly twice as many chronic health condition by the age of 45, compared to the general population, according to a new study led by St Jude Children’s Research Hospital (USA) and published in The Lancet.

15 Sep 2017

Simple blood test provides new treatment choices to lung cancer patients

A simple test which can detect gene mutations in tumour DNA from blood samples is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs.

15 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid to be published in The Lancet.

14 Sep 2017

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

14 Sep 2017

Arkansas professor makes strides toward developing enhanced cancer treatment

A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.

13 Sep 2017

MTI awards $25,000 grant to MDI Biological Laboratory scientist for peripheral neuropathy research

The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.

13 Sep 2017

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of cancer treatment that causes shooting or burning pain, numbness, tingling and cold sensitivity of the hands and feet for many cancer patients.

13 Sep 2017

Researchers identify protein that offers likely target for treating high-risk pediatric cancers

Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy--harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.

11 Sep 2017

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

A 14-year randomised trial in more than 600 patients has concluded that chemoradiation should remain the standard treatment for patients with locally advanced cervical cancer. The findings are reported today at the ESMO 2017 Congress in Madrid. The trial demonstrated no improved disease-free survival with neoadjuvant chemotherapy followed by surgery.

11 Sep 2017

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Increase in physical activity boosts breast cancer survivors’ mental processing speed

Analytical Science in Precision Medicine

As care shifts from hospital to home, guarding against infection falls to families

Research shows how bacteria inactivate common drug used to treat cancers

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Study highlights complexity of childhood cancer survivors’ medical needs

Simple blood test provides new treatment choices to lung cancer patients

FDA grants approval for new biosimilar to treat multiple types of cancer

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Arkansas professor makes strides toward developing enhanced cancer treatment

MTI awards $25,000 grant to MDI Biological Laboratory scientist for peripheral neuropathy research

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Researchers identify protein that offers likely target for treating high-risk pediatric cancers

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in